• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于乳腺癌治疗的可追踪三核铂配合物。

A trackable trinuclear platinum complex for breast cancer treatment.

作者信息

O'Carroll Sinéad, Slator Creina, de Paiva Raphael E F, Newsome Conor, Searle Bethany, Kk Sriram, Whittle Sylvia, Catley Thomas E, Scoditti Stefano, Mnich Katarzyna, Peterson Erica J, Hu Bin, Koblinski Jennifer E, Samali Afshin, McKee Vickie, Pyne Alice L B, Westerlund Fredrik, Farrell Nicholas P, Kellett Andrew

机构信息

School of Chemical Sciences, Dublin City University, Glasnevin, Dublin, D09 K20V, Ireland.

Department of Life Sciences, Chalmers University of Technology, Kemivägen 10, 412 96 Gothenburg, Sweden.

出版信息

Nucleic Acids Res. 2025 Jul 8;53(13). doi: 10.1093/nar/gkaf628.

DOI:10.1093/nar/gkaf628
PMID:40671528
Abstract

Cancer remains a leading cause of death, with triple-negative breast cancer (TNBC) being particularly significant due to limited treatment options. As such, there is interest in anticancer polynuclear platinum(II) complexes, attributed to their unique DNA-binding modes and potential against therapy-resistant cancer phenotypes. However, a persistent challenge with polynuclear compounds is their lack of cellular trackability, hindering their effectiveness and monitoring in clinical settings. Here, we report the preparation of a new azide-appended trinuclear platinum complex, N3-TriplatinNC, and characterize its DNA-targeting, cytotoxicity, and topoisomerase relaxation properties from the nanoscale to the macroscale. Using single-molecule biophysics and in-liquid atomic force microscopy, N3-TriplatinNC was identified as a powerful DNA recognition agent with remarkable potential towards the TNBC cell line, MDA-MB-231. Installation of the azide handle on the polynuclear complex was achieved using a first-in-class approach to produce a complex that retained analogous biological activity to the parent TriplatinNC. Importantly, the azide handle facilitates in situ click chemistry for tracking cellular localization, with subsequent xenograft studies demonstrating in vivo antitumoural potential.

摘要

癌症仍然是主要的死亡原因,三阴性乳腺癌(TNBC)由于治疗选择有限而尤为突出。因此,人们对抗癌多核铂(II)配合物感兴趣,这归因于它们独特的DNA结合模式以及对抗治疗抗性癌症表型的潜力。然而,多核化合物一直面临的挑战是它们缺乏细胞追踪能力,这阻碍了它们在临床环境中的有效性和监测。在此,我们报告了一种新的叠氮基附加三核铂配合物N3-TriplatinNC的制备,并从纳米尺度到宏观尺度对其DNA靶向、细胞毒性和拓扑异构酶松弛特性进行了表征。使用单分子生物物理学和液内原子力显微镜,N3-TriplatinNC被鉴定为一种强大的DNA识别剂,对TNBC细胞系MDA-MB-231具有显著潜力。通过一种一流的方法在多核配合物上安装叠氮基手柄,以产生一种保留与母体TriplatinNC类似生物活性的配合物。重要的是,叠氮基手柄便于进行原位点击化学以追踪细胞定位,随后的异种移植研究证明了其体内抗肿瘤潜力。

相似文献

1
A trackable trinuclear platinum complex for breast cancer treatment.一种用于乳腺癌治疗的可追踪三核铂配合物。
Nucleic Acids Res. 2025 Jul 8;53(13). doi: 10.1093/nar/gkaf628.
2
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
3
Platinum-containing regimens for metastatic breast cancer.转移性乳腺癌的含铂方案。
Cochrane Database Syst Rev. 2017 Jun 23;6(6):CD003374. doi: 10.1002/14651858.CD003374.pub4.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
6
Signature-based repurposed drugs resemble the inhibition of TGFβ-induced NDRG1 as potential therapeutics for triple-negative breast cancer.基于特征的重新利用药物类似于抑制TGFβ诱导的NDRG1,可作为三阴性乳腺癌的潜在治疗方法。
Int J Biol Sci. 2025 Jun 9;21(9):3949-3967. doi: 10.7150/ijbs.112645. eCollection 2025.
7
Novel indole Schiff base β-diiminato compound as an anti-cancer agent against triple-negative breast cancer: In vitro anticancer activity evaluation and in vivo acute toxicity study.新型吲哚席夫碱β-二亚胺化合物作为一种针对三阴性乳腺癌的抗癌剂:体外抗癌活性评价和体内急性毒性研究。
Bioorg Chem. 2024 Nov;152:107730. doi: 10.1016/j.bioorg.2024.107730. Epub 2024 Aug 16.
8
An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer.三阴性乳腺癌中与化疗耐药相关的癌症干细胞存活途径的最新进展。
Future Oncol. 2025 Mar;21(6):715-735. doi: 10.1080/14796694.2025.2461443. Epub 2025 Feb 12.
9
Platinum-based chemotherapy for early triple-negative breast cancer.含铂化疗治疗早期三阴性乳腺癌。
Cochrane Database Syst Rev. 2023 Sep 8;9(9):CD014805. doi: 10.1002/14651858.CD014805.pub2.
10
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.

本文引用的文献

1
Analysis of non-canonical three- and four-way DNA junctions.非规范三向和四向 DNA 连接点分析。
Methods. 2023 Nov;219:30-38. doi: 10.1016/j.ymeth.2023.09.002. Epub 2023 Sep 9.
2
Identification and characterization of plasmids carrying the mobile colistin resistance gene using optical DNA mapping.利用光学DNA图谱鉴定和表征携带可移动黏菌素抗性基因的质粒
JAC Antimicrob Resist. 2023 Feb 1;5(1):dlad004. doi: 10.1093/jacamr/dlad004. eCollection 2023 Feb.
3
DNA in nanochannels: theory and applications.纳米通道中的 DNA:理论与应用。
Q Rev Biophys. 2022 Oct 7;55:e12. doi: 10.1017/S0033583522000117.
4
Atomic Force Microscopy of DNA and DNA-Protein Interactions.原子力显微镜在 DNA 及其与蛋白质相互作用中的应用。
Methods Mol Biol. 2022;2476:43-62. doi: 10.1007/978-1-0716-2221-6_5.
5
High diversity of bla-encoding plasmids in Klebsiella pneumoniae isolated from neonates in a Vietnamese hospital.越南医院新生儿分离的肺炎克雷伯菌中 bla 编码质粒的多样性很高。
Int J Antimicrob Agents. 2022 Feb;59(2):106496. doi: 10.1016/j.ijantimicag.2021.106496. Epub 2021 Dec 16.
6
Cisplatin-cyclooxygenase inhibitor conjugates, free and immobilised in mesoporous silica SBA-15, prove highly potent against triple-negative MDA-MB-468 breast cancer cell line.顺铂-环氧化酶抑制剂偶联物,游离态和固载于介孔硅 SBA-15 中,对三阴性 MDA-MB-468 乳腺癌细胞系均具有高抗肿瘤活性。
Dalton Trans. 2022 Jan 17;51(3):857-869. doi: 10.1039/d1dt03265h.
7
Exploitation of Sulfated Glycosaminoglycan Status for Precision Medicine of Triplatin in Triple-Negative Breast Cancer.三阴性乳腺癌中三铂类药物精准医学用硫酸化糖胺聚糖状态的开发。
Mol Cancer Ther. 2022 Feb;21(2):271-281. doi: 10.1158/1535-7163.MCT-20-0969. Epub 2021 Nov 23.
8
Treatment landscape of triple-negative breast cancer - expanded options, evolving needs.三阴性乳腺癌的治疗现状——选择增多,需求变化。
Nat Rev Clin Oncol. 2022 Feb;19(2):91-113. doi: 10.1038/s41571-021-00565-2. Epub 2021 Nov 9.
9
A Click Chemistry Approach to Targeted DNA Crosslinking with cis-Platinum(II)-Modified Triplex-Forming Oligonucleotides.点击化学法用于靶向 DNA 交联的顺铂(II)修饰的三链体形成寡核苷酸。
Angew Chem Int Ed Engl. 2022 Jan 17;61(3):e202110455. doi: 10.1002/anie.202110455. Epub 2021 Dec 3.
10
Optical DNA Mapping of Plasmids Reveals Clonal Spread of Carbapenem-Resistant in a Large Thai Hospital.质粒的光学DNA图谱揭示了泰国一家大型医院中耐碳青霉烯类细菌的克隆传播情况。
Antibiotics (Basel). 2021 Aug 24;10(9):1029. doi: 10.3390/antibiotics10091029.